Cannabis is the most used drug of abuse worldwide. It is well established that the most
abundant phytocannabinoids in this plant are Δ9-tetrahydrocannabinol (THC) and …

Cannabis and classic psychedelics are controlled substances with emerging evidence of
efficacy in the treatment of a variety of psychiatric illnesses. Cannabis has largely not been …

The therapeutic benefits of the current medications for patients with psychiatric disorders
contrast with a great variety of adverse effects. The endocannabinoid system (ECS) …

Depression is characterized by continuous low mood and loss of interest or pleasure in
enjoyable activities. First-line medications for mood disorders mostly target the …

Abstract Background In 2018, Canada legalized recreational cannabis use with the purpose
of protecting youth and restricting access. However, concerns have been raised that this …

Context: Cannabis use among the general population has increased over time, in part due
to decriminalization of use and greater social acceptance of cannabis use. These changes …

Background The coexistence of childhood asthma and mental health (MH) conditions can
impact management and health outcomes but we need to better understand the etiology of …

Cannabis use is prevalent among individuals with binge eating (BE; ie, the inability to
control eating behavior). Yet, only two studies to date (both over 20 years old) have tested if …

Background Canada legalized recreational cannabis in 2018, and one of the primary
objectives of the Cannabis Act was to protect youth by reducing their access to cannabis and …

Background Despite limited clinical evidence of its efficacy, cannabis use has been
commonly reported for the management of various mental health concerns in naturalistic …